A Study of CAR-T Cells Targeting Both BCMA and GPRC5D in Treatment of Relapsed or Refractory Multiple Myeloma
Clinical trial NCT05325801 · UNKNOWN
Trial details
- NCT number
- NCT05325801
- Sponsor
- Zhejiang University
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-01
- Primary completion
- 2024-03-01
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.